TrialJAMA oncology2025

Stereotactic Body Radiotherapy vs Sorafenib Alone in Hepatocellular Carcinoma: The NRG Oncology/RTOG 1112 Phase 3 Randomized Clinical Trial.

Laura A Dawson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.